Who
Joseph M. Palumbo
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, BioVie.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 0
- Bought
- $21K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Feb 2022
- Last trade
- 28 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 28 Aug 2026 | BIVI BioVieBiotechnology | SEC FORM 4 Bought | $10K4,843 at $2.16 | filing |
| 28 Aug 2026filed 28 Aug 2026 | BIVI BioVieBiotechnology | SEC FORM 4 Bought | $10K4,843 at $2.16 | filing |
| 5 Jan 2026filed 9 Jan 2026 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —132,000 at $0.00 | filing |
| 5 Jan 2026filed 9 Jan 2026 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —132,000 at $0.00 | filing |
| 20 Dec 2024filed 7 Jan 2025 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,417 at $0.00 | filing |
| 24 Jun 2024filed 12 Jul 2024 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,000 at $0.00 | filing |
| 24 Jun 2024filed 12 Jul 2024 | BIVI BioVieBiotechnology | SEC FORM 4 Code A | —116,000 at $0.00 | filing |
| 24 Jun 2024filed 12 Jul 2024 | BIVI BioVieBiotechnology | SEC FORM 4 Code F | $14K29,000 at $0.47 | filing |
| 15 Feb 2024filed 12 Jul 2024 | BIVI BioVieBiotechnology | SEC FORM 4 Code F | $2,9222,476 at $1.18 | filing |
| 7 Jun 2023filed 3 Jul 2023 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 16 Feb 2023filed 12 Jul 2024 | BIVI BioVieBiotechnology | SEC FORM 4 Code F | $14K2,476 at $5.51 | filing |
| 16 Feb 2023filed 22 Feb 2023 | BIVI BioVieBiotechnology | SEC FORM 4 Code F | $15K2,476 at $6.12 | filing |
| 23 Nov 2022filed 18 Jan 2023 | BIVI BioVieBiotechnology | SEC FORM 4 Code A | —39,624 at $0.00 | filing |
| 1 Feb 2022filed 17 Feb 2022 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,167 at $0.00 | filing |
News
BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual MeetingBIVI · manilatimes.net · 19 Oct 2026
0 headlines in the last 90 days name Joseph M. Palumbo; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.